NRX Pharmaceuticals Inc. (NRXP)
NASDAQ · Healthcare
NRX Pharmaceuticals Inc. Operating Income 2023–2025
NRX Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- NRX Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -4.7 M, a 23.26% increase year-over-year.
- NRX Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -15.6 M.
- NRX Pharmaceuticals Inc. annual operating income for 2025 was -16.2 M, a 12.31% decrease from 2024.
- NRX Pharmaceuticals Inc. annual operating income for 2024 was -18.5 M, a 33.53% decrease from 2023.
- NRX Pharmaceuticals Inc. annual operating income for 2023 was -27.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
NRX Pharmaceuticals Inc. Operating Income — FAQ
NRX Pharmaceuticals Inc. (NRXP) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is NRX Pharmaceuticals Inc.'s operating income?
NRX Pharmaceuticals Inc. (NRXP) reported operating income of -$16M for fiscal 2025.
Where can I see NRXP's operating income history?
The chart and table above show NRX Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.